A COMBINATION OF RILPIVIRINE OR AN EQUIVALENT THERAPEUTIC FORM THEREFROM IN SUCH AS PROTECTED BY THE BASIC PATENT, SUCH AS A PHARMACEUTICALLY ACCEPTABLE SALT OF RILPIVIRINE, INCLUDING THE RILPIVIRINE HYDROCHLORIDE SALT, TENOFOVIR, IN PARTICULAR TENOFOVIR DISOPROXIL FUMARATE, AND THE EMTRICITABINE

• 收藏
• 分享

专利权人:

JANSSEN SCIENCES IRELAND UC

发明人:

申请号：

LU92855

公开号：

LU92855I2

申请日:

2015.10.21

申请国别(地区):

LU

年份:

2015

代理人:

摘要：

The present invention concerns combinations of a pyrimidine containing NNRTI with nucleoside reverse transcriptase inhibitors and/or nucleotide reverse transcriptase inhibitors useful for the treatment of HIV infected patients or for the prevention of HIV transmission or infection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/